Clover Biopharmaceuticals, Ltd. (2197.HK)

HKD 0.26

(0.0%)

Long Term Debt Summary of Clover Biopharmaceuticals, Ltd.

  • Clover Biopharmaceuticals, Ltd.'s latest annual long term debt in 2023 was 7.85 Million CNY , down -78.62% from previous year.
  • Clover Biopharmaceuticals, Ltd.'s latest quarterly long term debt in 2024 Q1 was - CNY , down 0.0% from previous quarter.
  • Clover Biopharmaceuticals, Ltd. reported annual long term debt of 36.73 Million CNY in 2022, down -20.89% from previous year.
  • Clover Biopharmaceuticals, Ltd. reported annual long term debt of 46.44 Million CNY in 2021, up 157.19% from previous year.
  • Clover Biopharmaceuticals, Ltd. reported quarterly long term debt of - CNY for 2024 Q2, down 0.0% from previous quarter.
  • Clover Biopharmaceuticals, Ltd. reported quarterly long term debt of 7.85 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Clover Biopharmaceuticals, Ltd. (2023 - 2019)

Historical Annual Long Term Debt of Clover Biopharmaceuticals, Ltd. (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 7.85 Million CNY -78.62%
2022 36.73 Million CNY -20.89%
2021 46.44 Million CNY 157.19%
2020 18.05 Million CNY 69.63%
2019 10.64 Million CNY 0.0%

Peer Long Term Debt Comparison of Clover Biopharmaceuticals, Ltd.

Name Long Term Debt Long Term Debt Difference
Uni-Bio Science Group Limited 30.61 Million HKD 74.347%
CK Life Sciences Int'l., (Holdings) Inc. 4.27 Billion HKD 99.816%